Source: Investing.com ↗

Protagonist Therapeutics authorizes $300 million buyback plan

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,158.01

+0.98%

ETH/USDT

$2,743.41

+0.67%

ZEC/USDT

$1,625.83

+7.61%

XRP/USDT

$1.62

+6.72%